Trial reportBMC cancer2026
Effectiveness of a digital health intervention on the supportive care needs and quality of life in Mexican patients with breast cancer: a randomized clinical trial.
Trial report in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05925257 (Design and Evaluation of the Effectiveness of a Digital Health Intervention to Improve Health Care and Outcomes for Cancer Patients), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Design and Evaluation of the Effectiveness of a Digital Health Intervention to Improve Health Care and Outcomes for Cancer Patients
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Mexico, unmet supportive care needs are common among women with breast cancer treated in public hospitals, particularly needs regarding health systems and information. This study assessed the effectiveness of a digital patient-reported outcome (ePRO) intervention on these needs and quality of life.
methodsWe conducted a parallel arm, individually randomized clinical trial with 410 Mexican women undergoing chemotherapy at four hospitals of the Mexican Institute of Social Security. Participants were assigned to either an intervention group, which used the “OncoMama” ePRO application with proactive nursing follow-up, or a control group receiving standard care and links to breast cancer-related audiovisual resources. The primary outcomes were unmet needs related to health systems and information and overall quality of life at 6 months (primary effectiveness) and 9 months (sustainment). The intervention's effectiveness was evaluated by comparing the medians using quantile regression at 6 and 9 months and applying an intention-to-treat approach with inverse probability of censoring weighting for missing data.
resultsAt 6 months, the intervention group showed statistically significant reductions compared to the control group in health systems and information needs (11.4 vs 20.5 points, p = 0.003) as well as improvement in overall quality of life (86.2 vs 80.9 points, p = 0.001). By 9 months, these effects remained significant for both information needs (4.5 vs 13.6 points, p = 0.003) and quality of life (87.4 vs 82.5 points, p = 0.002).
conclusionsePRO intervention proved effective in reducing the need for supportive care and improving the overall quality of life of women with early-stage or locally advanced breast cancer undergoing chemotherapy.
trial registrationThis randomized controlled trial was registered at ClinicalTrials.gov on June 21, 2023, with the NCT identification number NCT05925257.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.